The Pharmaceutical Research and Manufacturers of America is floating proposals to lower prescription drug costs in Medicare Part B and Part D through voluntary demonstration projects in which manufacturer discounts would help lower beneficiary cost sharing.
The proposals could serve as an alternative to the so-called “most favored nation” executive order the President has threatened to...







